Heart failure & cardiomyopathies

Mid-Term Reassessment of Waitlist and Posttransplant Outcomes Under the 2018 Heart Allocation System: Improved All-Cause Survival

Circ Heart FailPublished Retrospective cohort study

Authors' conclusion

Despite the changes in donor and recipient profiles following the 2018 allocation system change, this mid-term reassessment demonstrates its success in significantly improving waitlist survival, while maintaining comparable posttransplant survival.

Study context

Population
Adult waitlisted and transplanted patients undergoing isolated heart transplantation, UNOS registry30,620 waitlisted
Exposure
Postpolicy vs prepolicy
Outcome
Waitlist outcomes (transplantation, delisting due to death/clinical deterioration, all-cause survival from initial waitlisting) and posttransplant survival
Follow-up
1 year (waitlist); 4 years (posttransplant)
Methodological detailsregistry-based (UNOS), seasonally matched, propensity-score matched, multivariable Cox regression
  • Registry-based (UNOS)
  • Seasonally matched
  • Propensity-score matched
  • Multivariable Cox regression

Main finding

As reported in the abstract

Waitlist outcomes · 1 year
Postpolicy vs PrepolicySubhazard ratio (95% CI)P value
Transplantation
2.06(2.00–2.12)
P < 0.001
Delisting
0.58(0.53–0.63)
P < 0.001

Observational data: associations, not effects.

Further findings

4-year post-transplant survival (posttransplant analysis)

Similar between the groups (83.3% vs 82.8%)
P = 0.593
Comparable 4-year post-transplant survival persisted in the propensity score-matched comparison and multivariable Cox regression
  • 13 712 recipients analysed; 4597 (33.5%) transplanted after the policy change

Original publication

Mid-Term Reassessment of Waitlist and Posttransplant Outcomes Under the 2018 Heart Allocation System: Improved All-Cause Survival. Circ Heart Fail. Published 2 July 2025. doi:10.1161/circheartfailure.124.012663

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.